Nicholas S Hopkinson

Sep 10, 2024 | bmj.com | Martin McKee |Trisha Greenhalgh |Asif Qasim |Nicholas S Hopkinson

Martin McKee, professor of European Public Health1, Trisha Greenhalgh, professor of Primary Care Health Sciences2, Asif Qasim, consultant cardiologist3, Nicholas S Hopkinson, professor of Respiratory Medicine4, David Nicholl, clinical lead for Neurology5 1London School of Hygiene & Tropical Medicine 2University of Oxford 3Croydon University Hospital 4National Heart and Lung Institute, Imperial College 5Sandwell & West Birmingham NHS Trust, Birmingham “… a range of collective failures in...

Aug 9, 2024 | bmj.com | Nicholas S Hopkinson

Nicholas S Hopkinson, professorNational Heart and Lung Institute, Imperial College LondonEvery day and in every country around the world people are harmed, and robbed of their life chances, by social structures and institutions. Their lives are cut short or limited by ill health.

Jun 27, 2024 | bmjopenrespres.bmj.com | William H McNulty |Simon Jordan |Nicholas S Hopkinson

Chronic obstructive pulmonary diseaseOriginal article Attitudes and access to lung volume reduction surgery for COPD: a survey by the British Thoracic Society Statistics from Altmetric.com Request Permissions If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Feb 20, 2024 | bmj.com | Nicholas S Hopkinson

Nicholas S Hopkinson, professor of respiratory medicineImperial College LondonLast week was the 70th anniversary of the UK government’s acceptance that smoking causes lung cancer.1 Cases of this previously rare disease had risen 10-fold since the end of the First World War, and epidemiological work by Richard Doll and Austin Bradford Hill had put the role of smoking as a cause beyond doubt.23 The health secretary Iain Macleod famously chain-smoked his way through the press conference.

Jan 1, 2024 | openres.ersjournals.com | Bill King |Andrew Cumella |Nicholas S Hopkinson |John R. Hurst

IntroductionChronic lung diseases are a leading cause of morbidity and mortality worldwide [1]. A key contributor to the burden of chronic lung disease at a patient and health system level is acute exacerbations of respiratory symptoms. These exacerbations are commonly caused by respiratory viral infections [2]. Severe exacerbations that result in hospitalisation are costly and often make up a large majority of the treatment costs of chronic lung disease [3–6].